| Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting J Huang, X Li, X Shi, M Zhu, J Wang, S Huang, X Huang, H Wang, L Li, ... Journal of hematology & oncology 12, 1-22, 2019 | 298 | 2019 |
| High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically … X Li, C Li, J Jin, J Wang, J Huang, Z Ma, X Huang, X He, Y Zhou, Y Xu, ... EBioMedicine 38, 47-56, 2018 | 60 | 2018 |
| Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development Y Yao, F Li, J Huang, J Jin, H Wang Experimental Hematology & Oncology 10 (1), 39, 2021 | 42 | 2021 |
| Effects of different shear rates on the attachment and detachment of platelet thrombi X Shi, J Yang, J Huang, Z Long, Z Ruan, B Xiao, X Xi Molecular Medicine Reports 13 (3), 2447-2456, 2016 | 40 | 2016 |
| Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study X Lin, J Wang, X Huang, H Wang, F Li, W Ye, S Huang, J Pan, Q Ling, ... Aging (Albany NY) 13 (7), 10468, 2021 | 33 | 2021 |
| High expression of TET1 predicts poor survival in cytogenetically normal acute myeloid leukemia from two cohorts J Wang, F Li, Z Ma, M Yu, Q Guo, J Huang, W Yu, Y Wang, J Jin EBioMedicine 28, 90-96, 2018 | 33 | 2018 |
| Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia J Wang, W Ye, X Yan, Q Guo, Q Ma, F Lin, J Huang, J Jin Journal of translational medicine 17, 1-9, 2019 | 30 | 2019 |
| Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine X Li, X Yan, W Guo, X Huang, J Huang, M Yu, Z Ma, Y Xu, SJ Huang, C Li, ... Biomedicine & Pharmacotherapy 90, 699-704, 2017 | 28 | 2017 |
| Prognostic impact of MYH9 expression on patients with acute myeloid leukemia M Yu, J Wang, Z Zhu, C Hu, Q Ma, X Li, X Yin, J Huang, T Zhang, Z Ma, ... Oncotarget 8 (1), 156, 2017 | 25 | 2017 |
| Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia S Huang, J Pan, J Jin, C Li, X Li, J Huang, X Huang, X Yan, F Li, M Yu, ... Cancer Letters 461, 132-143, 2019 | 18 | 2019 |
| Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia J Wang, M Yu, Q Guo, Q Ma, C Hu, Z Ma, X Yin, X Li, Y Wang, H Pan, ... Scientific Reports 7 (1), 45960, 2017 | 18 | 2017 |
| The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia X Li, X Yin, H Wang, J Huang, M Yu, Z Ma, C Li, Y Zhou, X Yan, SJ Huang, ... Oncotarget 8 (8), 12764, 2017 | 17 | 2017 |
| Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy J Huang, X Shi, W Xi, P Liu, Z Long, X Xi Journal of Hematology & Oncology 8, 1-14, 2015 | 16 | 2015 |
| Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma X Yan, Y Zhou, S Huang, X Li, M Yu, J Huang, J Wang, Z Ma, J Jin, J Pan, ... Journal of Cancer Research and Clinical Oncology 144, 697-706, 2018 | 9 | 2018 |
| Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases X Zhou, X Ye, Y Ren, C Mei, L Ma, J Huang, W Xu, J Wei, L Ye, W Mai, ... Frontiers of Medicine 10, 430-436, 2016 | 9 | 2016 |
| Prognostic utility of six mutated genes for older patients with acute myeloid leukemia J Wang, Z Ma, Q Wang, Q Guo, J Huang, W Yu, H Wang, J Huang, ... International Journal of Cancer 142 (8), 1664-1670, 2018 | 8 | 2018 |
| Functional effect of the mutations similar to the cleavage during platelet activation at integrin β3 cytoplasmic tail when expressed in mouse platelets X Shi, J Yang, X Cui, J Huang, Z Long, Y Zhou, P Liu, L Tao, Z Ruan, ... PLoS One 11 (11), e0166136, 2016 | 8 | 2016 |
| Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model J Huang, Y Zhou, X Su, Y Lyu, L Tao, X Shi, P Liu, Z Long, Z Ruan, B Xiao, ... Frontiers of Medicine 10, 311-319, 2016 | 2 | 2016 |
| Prognostic significance of IDH1 and IDH2 mutations in older patients with primary cytogenetically normal acute myeloid leukemia J Wang, Z Ma, Q Wang, M Yu, X Yin, X Li, S Suo, D Shen, Y Wang, ... Blood 128 (22), 5058, 2016 | 1 | 2016 |
| Analysis on bioactivity of HIV-1 integrase by ELISA method WH Feng, JS Huang, JB Zhan Zhejiang da xue xue bao. Yi xue ban= Journal of Zhejiang University. Medical …, 2007 | 1 | 2007 |
